Thirty Years of Hydroxyurea for Sickle Cell Anemia — Scientific Progress, Global Health Gaps
Enrico Costa(Brigham and Women's Hospital), Lucio Luzzatto(Muhimbili University of Health and Allied Sciences), Léon Tshilolo(National Institute of Biomedical Research), Russell E. Ware(Cincinnati Children's Hospital Medical Center)
Cited by 3
Related Papers
Management of Sickle Cell Disease
|JAMA|2014|1.6k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Natural History of Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|1995|900
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|578
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members
|Survey of Anesthesiology|2015|270